<DOC>
	<DOC>NCT01489852</DOC>
	<brief_summary>The purpose of this study is to assess whether estrogen pre-treatment can allow retrieval of 2 additional oocytes in GnRH antagonist protocol.</brief_summary>
	<brief_title>Estrogen Pretreatment Prior to GnRH Antagonist Protocol</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>regular normoovulatory cycles (28 to 35 days) age &lt; 38 years, body mass index (BMI) between 18 and 30 first or second IVF/ICSI attempt high basal levels of serum FSH or E2, less than 5 follicles at the antral follicular count performed on day 3 of a spontaneous cycle, history of high (&gt;20 oocytes) or low (&lt; 5 oocytes) ovarian response in a previous IVF attempt</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Assisted reproductive treatment</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>Estrogen pre-treatment</keyword>
	<keyword>Ovarian stimulation</keyword>
</DOC>